|
π―π΅ Product recall due N-nitroso-diisopropanolamine
|
|
1
|
237
|
October 17, 2026
|
|
Effective management of N-nitrosamines associated with leachables from packaging systems
|
|
7
|
547
|
October 16, 2026
|
|
LTL Application Monthly Administration
|
|
1
|
142
|
October 16, 2026
|
|
π―π΅ Recommendations by Japanese Society of Generic and Biosimilar Medicines
|
|
0
|
94
|
October 16, 2026
|
|
Managing nitrosamine toxicological risk in late-stage development
|
|
1
|
191
|
October 15, 2026
|
|
Nitrosation of bilastine
|
|
10
|
491
|
October 15, 2026
|
|
πΈπ¦ Saudi FDA requesting Nitrosamines Risk Assessments
|
|
6
|
2113
|
October 13, 2026
|
|
N-nitroso Des-ethyl Abemaciclib
|
|
0
|
97
|
October 12, 2026
|
|
Synthesis of N-Nitroso Finerenone
|
|
10
|
1179
|
October 12, 2026
|
|
Formation of N-nitroso compounds: Chemistry, kinetics, and in vivo occurrence
|
|
0
|
194
|
October 9, 2026
|
|
Amine nitrosation mechanism (organic medium)
|
|
1
|
145
|
October 9, 2026
|
|
In situ Formation and NNNT increase over time
|
|
6
|
384
|
October 7, 2026
|
|
Call to review USP Risk Assessment Review Toolbox
|
|
127
|
4455
|
October 2, 2026
|
|
Confirmatory testing - on how many batches?
|
|
6
|
416
|
October 2, 2026
|
|
Excipient nitrite levels are not static material attributes: Nitrite generation from environmental NOx and implications for drug product manufacturing
|
|
12
|
908
|
October 2, 2026
|
|
Qualitative & Quantitative Analysis of Nitrosamines by FTIR
|
|
8
|
447
|
September 28, 2026
|
|
Issue Regarding Purchase of N-Nitroso N-Desmethyl Rosuvastatin Reference Standard
|
|
12
|
582
|
September 26, 2026
|
|
Applicability of the ICH M7 Guidelines for Assessing Less-than-Lifetime Exposure to Nitrosamine Impurities in Drug Products-Pub
|
|
10
|
831
|
September 25, 2026
|
|
Theoretical evaluation of NDSRIs
|
|
13
|
734
|
September 25, 2026
|
|
Is Sensitivity really the biggest challenge or is it sample preparation?
|
|
1
|
227
|
September 24, 2026
|
|
Ng/day versus ppm - which to use with regulatory authorities?
|
|
8
|
446
|
September 23, 2026
|
|
Why Accurate Nitrosamine Data Matters: Key Challenges and Considerations-Webinar
|
|
0
|
214
|
September 18, 2026
|
|
Nitrosamine Analytical Method Development
|
|
4
|
331
|
September 18, 2026
|
|
The Next Frontier in Nitrosamines Testing: Detection and Risk Assessment in Packaging and IV Infusion Bags
|
|
0
|
197
|
September 17, 2026
|
|
Deactivation feature on a 8-member ring with side chains?
|
|
8
|
359
|
September 15, 2026
|
|
Maximum daily dose
|
|
3
|
429
|
September 15, 2026
|
|
N-Nitroso Abemaciclib
|
|
15
|
1270
|
September 14, 2026
|
|
π¨βπ» Dashboard Containing Published AI Limits
|
|
33
|
4774
|
September 8, 2026
|
|
EDTA-Related Nitrosamine Impurities: Two Critical Pain Points in Pharma R&D
|
|
8
|
880
|
September 7, 2026
|
|
A Derivatization Free HPLCβUV Method for Nitrite Quantification in Strongly Matrix-Affected Pharmaceutical Excipients-Pubγ
|
|
3
|
298
|
September 5, 2026
|